enGenome provides bioinformatics solutions for translational research and clinical routine.
enGenome has raised €3.7M across 1 funding round from 1 investor, most recently a round in Oct 2021. Based in Pavia, Italy; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-10-22 | Other | €3.7M |
| EIC Accelerator |
| View deal → |
